These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

654 related items for PubMed ID: 17962701

  • 1. Toll-like receptors 3 and 4 are expressed by human bone marrow-derived mesenchymal stem cells and can inhibit their T-cell modulatory activity by impairing Notch signaling.
    Liotta F, Angeli R, Cosmi L, Filì L, Manuelli C, Frosali F, Mazzinghi B, Maggi L, Pasini A, Lisi V, Santarlasci V, Consoloni L, Angelotti ML, Romagnani P, Parronchi P, Krampera M, Maggi E, Romagnani S, Annunziato F.
    Stem Cells; 2008 Jan; 26(1):279-89. PubMed ID: 17962701
    [Abstract] [Full Text] [Related]

  • 2. Toll-like receptors 2 and 4 mediate the capacity of mesenchymal stromal cells to support the proliferation and differentiation of CD34⁺ cells.
    Wang X, Cheng Q, Li L, Wang J, Xia L, Xu X, Sun Z.
    Exp Cell Res; 2012 Feb 01; 318(3):196-206. PubMed ID: 22100911
    [Abstract] [Full Text] [Related]

  • 3. Toll-like receptor engagement enhances the immunosuppressive properties of human bone marrow-derived mesenchymal stem cells by inducing indoleamine-2,3-dioxygenase-1 via interferon-beta and protein kinase R.
    Opitz CA, Litzenburger UM, Lutz C, Lanz TV, Tritschler I, Köppel A, Tolosa E, Hoberg M, Anderl J, Aicher WK, Weller M, Wick W, Platten M.
    Stem Cells; 2009 Apr 01; 27(4):909-19. PubMed ID: 19353519
    [Abstract] [Full Text] [Related]

  • 4. Ligation of TLR2 and TLR4 on murine bone marrow-derived mesenchymal stem cells triggers differential effects on their immunosuppressive activity.
    Lei J, Wang Z, Hui D, Yu W, Zhou D, Xia W, Chen C, Zhang Q, Wang Z, Zhang Q, Xiang AP.
    Cell Immunol; 2011 Apr 01; 271(1):147-56. PubMed ID: 21757189
    [Abstract] [Full Text] [Related]

  • 5. Fetal BM-derived mesenchymal stem cells promote the expansion of human Th17 cells, but inhibit the production of Th1 cells.
    Guo Z, Zheng C, Chen Z, Gu D, Du W, Ge J, Han Z, Yang R.
    Eur J Immunol; 2009 Oct 01; 39(10):2840-9. PubMed ID: 19637224
    [Abstract] [Full Text] [Related]

  • 6. Immunosuppressive effects of mesenchymal stem cells: involvement of HLA-G.
    Nasef A, Mathieu N, Chapel A, Frick J, François S, Mazurier C, Boutarfa A, Bouchet S, Gorin NC, Thierry D, Fouillard L.
    Transplantation; 2007 Jul 27; 84(2):231-7. PubMed ID: 17667815
    [Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 9. Adipose tissue-derived mesenchymal stem cells are more potent suppressors of dendritic cells differentiation compared to bone marrow-derived mesenchymal stem cells.
    Ivanova-Todorova E, Bochev I, Mourdjeva M, Dimitrov R, Bukarev D, Kyurkchiev S, Tivchev P, Altunkova I, Kyurkchiev DS.
    Immunol Lett; 2009 Sep 22; 126(1-2):37-42. PubMed ID: 19647021
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Notch signaling: a novel regulating differentiation mechanism of human umbilical cord blood-derived mesenchymal stem cells into insulin-producing cells in vitro.
    Hu YH, Wu DQ, Gao F, Li GD, Zhang XC.
    Chin Med J (Engl); 2010 Mar 05; 123(5):606-14. PubMed ID: 20367990
    [Abstract] [Full Text] [Related]

  • 13.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Role for interferon-gamma in the immunomodulatory activity of human bone marrow mesenchymal stem cells.
    Krampera M, Cosmi L, Angeli R, Pasini A, Liotta F, Andreini A, Santarlasci V, Mazzinghi B, Pizzolo G, Vinante F, Romagnani P, Maggi E, Romagnani S, Annunziato F.
    Stem Cells; 2006 Feb 05; 24(2):386-98. PubMed ID: 16123384
    [Abstract] [Full Text] [Related]

  • 16.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 17. Comparison of multipotent differentiation potentials of murine primary bone marrow stromal cells and mesenchymal stem cell line C3H10T1/2.
    Zhao L, Li G, Chan KM, Wang Y, Tang PF.
    Calcif Tissue Int; 2009 Jan 05; 84(1):56-64. PubMed ID: 19052794
    [Abstract] [Full Text] [Related]

  • 18. The immunosuppressive effects of human bone marrow-derived mesenchymal stem cells target T cell proliferation but not its effector function.
    Ramasamy R, Tong CK, Seow HF, Vidyadaran S, Dazzi F.
    Cell Immunol; 2008 Feb 05; 251(2):131-6. PubMed ID: 18502411
    [Abstract] [Full Text] [Related]

  • 19. Notch1 co-localizes with CD4 on activated T cells and Notch signaling is required for IL-10 production.
    Benson RA, Adamson K, Corsin-Jimenez M, Marley JV, Wahl KA, Lamb JR, Howie SE.
    Eur J Immunol; 2005 Mar 05; 35(3):859-69. PubMed ID: 15688350
    [Abstract] [Full Text] [Related]

  • 20.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 33.